News
Significant progress is being made toward diagnosis, evaluation and management of sensori-motor dysfunction, gut microbiota, gut-brain axis, nutrition, eosinophilic esophagitis. Read the most recent news here.
Graphical Abstract: Impact of COVID-19 on the brain-gut-microbiota axis in Parkinson’s disease
Dr. Cristian Follmer from Laboratory of Biological Chemistry of Neurodegenerative Disorders, Institute of Chemistry, Federal University of Rio de Janeiro, has recently summarized new observations regarding a potential impact of COVID-19 on Parkinson’s disease with respect to the gut microbiome imbalance and neuroinflammation.
President Welcome
Goodbye and welcome! After many years of a very successfully presidency Giovanni Barbara stepped down as president of the ESNM. We are happy to announce Qasim Aziz as his worthy successor. Good luck for the next years to come!
UEG Week Virtual 2020 Congress Review available
A digi-book which summarises scientific highlights and latest news in GI diseases, presented at the first virtual UEG Week.
ESNM recommendations for conducting gastrointestinal motility and function testing in the recovery phase of the COVID‐19 pandemic
During the peak of the corona virus disease 2019 (COVID‐19) pandemic, care for patients with gastrointestinal motility and functional disorders was largely suspended. ESNM provides recommendations based on the best current evidence and a pragmatic approach to ensure the safe conduct of motility and function testing for both healthcare professionals and patients.
ESGE Guidelines on Endoscopic Management of Gastrointestinal Motility Disorders
Therapeutic gastrointestinal endoscopy is rapidly taking a major role in the management of motility disorders of the digestive tract. Indeed, several disorders like achalasia, GERD, gastroparesis, intractable constipation, can be potentially currently managed by interventional endoscopy.